传统降尿酸治疗对单钠尿酸盐结晶沉积的影响
这项前瞻性研究纳入83例符合ACR/EULAR分类标准且DECT可见MSU沉积的痛风患者,接受生活方式干预或传统降尿酸治疗平均18个月。结果显示生活方式干预和黄嘌呤氧化酶抑制剂可显著减少MSU沉积负荷,而停药者无变化。
要点
- 生活方式干预可显著减少MSU沉积体积和评分。
- 别嘌醇和非布司他可显著减少MSU沉积负荷。
- 停用降尿酸治疗者MSU沉积和血尿酸均无变化。
核心结论
- 生活方式干预和黄嘌呤氧化酶抑制剂可显著减少痛风患者的MSU沉积负荷。
- 传统痛风治疗不仅降低血尿酸水平,还减少病理性MSU沉积。
研究设计与样本
- 前瞻性研究,纳入83例符合ACR/EULAR分类标准且DECT可见MSU沉积的痛风患者。
- 患者接受生活方式干预或传统降尿酸治疗平均18个月后复查DECT。
- MSU沉积通过体积测量量化,并用半定量评分验证。
主要发现
- 总体人群平均血尿酸从7.2 mg/dl降至5.8 mg/dl。
- 停药者MSU沉积和血尿酸水平无变化。
- 生活方式干预组MSU体积P=0.007、评分P=0.001显著下降。
- 别嘌醇组MSU体积和评分P<0.001显著下降。
- 非布司他组MSU体积P<0.001、评分P=0.001显著下降。
临床怎么用
- 对痛风患者应积极采用生活方式干预和黄嘌呤氧化酶抑制剂治疗以促进MSU沉积消退。
- 避免随意停用降尿酸治疗,因停药后MSU沉积无改善。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Few studies have systematically and quantitatively addressed the impact of urate-lowering therapy on monosodium urate (MSU) deposits. This study was undertaken to analyze the effect of lifestyle measures and conventional urate-lowering therapy on MSU deposits in patients with gout. METHODS: In this prospective study, subjects with gout according to the American College of Rheumatology/European League Against Rheumatism classification criteria and presence of MSU deposits seen on dual-energy computed tomography (DECT) scans received either lifestyle intervention or conventional urate-lowering therapy for a mean period of 18 months before a follow-up DECT scan. Detected MSU deposits were quantified by volumetric measurement and validated by semiquantitative scoring, and baseline and follow-up measurements were compared. RESULTS: Baseline and follow-up DECT scans were available for all 83 subjects. Six subjects discontinued treatment, and 77 subjects underwent a lifestyle intervention (n = 24) or were treated with allopurinol (n = 29), febuxostat (n = 22), or benzbromarone (n = 2) over the entire observation period. The mean serum uric acid (UA) level decreased from 7.2 to 5.8 mg/dl in the overall population. In patients who discontinued treatment, no change in MSU deposits or serum UA levels was observed. The burden of MSU deposits significantly decreased in patients undergoing lifestyle intervention (MSU volume P = 0.007; MSU score P = 0.001), and in patients treated with allopurinol (MSU volume and score P < 0.001) or febuxostat (MSU volume P < 0.001; MSU score P = 0.001). No significant decline in MSU deposits was noted in patients who discontinued treatment. CONCLUSION: These data show that lifestyle intervention and xanthine oxidase inhibitors significantly decrease the MSU deposit burden. Hence, conventional gout therapy not only lowers serum UA levels, but also reduces pathologic MSU deposits.
引用
- Ellmann H, Bayat S, Araujo E, et al. Effects of Conventional Uric Acid-Lowering Therapy on Monosodium Urate Crystal Deposits. Arthritis Rheumatol. 2019. PMID: 31353871. doi:10.1002/art.41063
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。